Answers are grounded in this paper and cite their sources.
Systematic review demonstrates the evolution of molecular and multi-omics biomarkers in blast lung injury, highlighting opportunities for improved early diagnosis and targeted therapy.
Blast lung injury (BLI) poses great challenges for early diagnosis and precise treatment. This review systematically summarizes the evolution of relevant biomarkers from conventional inflammatory indicators to newly identified molecular markers related to cell injury, inflammation, oxidative stress, and epigenetic regulation. It also discusses imaging combination strategies, multi-omics applications, current translational obstacles, and future research trends. This work provides valuable theoretical references for improving diagnostic accuracy, optimizing prognostic evaluation, and developing targeted therapies for BLI.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: